Summary
ITP in hemophiliacs may produce severe bleeding complications. We here report on an eight-year-old boy suffering from severe hemophilia A, who developed ITP and an acquired impaired immune function similar to AIDS. Steroid therapy reverted the thrombocyte count to normal, however it had to be discontinued because of a severe Cushing syndrome. The thrombocytopenia also responded to IgG-therapy and the patient is treated with a long term schedule according to Imbach. It is of interest that the impaired T-helper/T-suppressor cell ratio (0.45) improved to a value of 1.0 after initiation of this therapeutic regimen. We conclude from our observation that i.v. immunoglobulin therapy is of particular value for the treatment of ITP in patients with impaired cellular immunity.
Similar content being viewed by others
References
Hruby MA (1977) Coexistent hemophilia A and idiopathic thrombocytopenic purpura. J Pediatr 90: 773–775
Imbach P, Baradun S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A, Rossi E, Schöni M, Vest M, Wagner HP (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1: 1128–1231
Morris L, Distenfeld A, Amorosi E, Karpatkin S (1982) Autoimmune thrombocytopenic purpura in homosexual men. Ann Intern Med 96: 714–717
Ratnoff OD, Menitove JE, Aster RH, Lederman MM (1983) Coincident classic hemophilia and “idiopathic” thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII). N Engl J Med 308: 439–442
Suffredini A, Qureshi GD (1982) Concomitant hemophilia and thrombocytopenia. JAMA 247: 2497–2498
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zeitlhuber, U., Haschke, F., Püspök, R. et al. Hemophilia and thrombocytopenia in a patient with impaired cellular immunity. Blut 48, 393–395 (1984). https://doi.org/10.1007/BF00319970
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00319970